Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Diagnos Inc V.ADK

Alternate Symbol(s):  DGNOF

Healthcare Medical Devices
DIAGNOS Inc. is a Canadian company, which is engaged in early detection of critical health problems based on its FLAIRE artificial intelligence (AI) platform. FLAIRE allows for modifying and developing of applications, such as Computer Assisted Retina Analysis (CARA). CARA’s image enhancement algorithms provide sharper, clearer and easier-to-analyze retinal images. CARA is a tool for real-time... see more

Recent & Breaking News (TSXV:ADK)

DIAGNOS Announces Resignation to the Board of Directors

Marketwired November 19, 2014

DIAGNOS Announces the Opening of a Clinical Retinopathy Screening Office in Algeria

Marketwired October 16, 2014

DIAGNOS Healthcare's Commercialization of CARA Passes $1M in Bookings

Marketwired October 2, 2014

DIAGNOS Announces Amendment to its Stock Option Plan

Marketwired September 25, 2014

DIAGNOS Announces Contract with Dr. Kovil's Diabetes Care Centre in Mumbai

Marketwired September 16, 2014

DIAGNOS Announces Contract With Dr. Vishal Gupta's Diabetes and Endocrine Clinic in Mumbai

Marketwired September 9, 2014

DIAGNOS Announces Grant of Stock Options

Marketwired September 8, 2014

DIAGNOS Announces First Retinopathy Screening Unit in Turkey

Marketwired September 3, 2014

DIAGNOS Announces First Retinopathy Screening Unit in Eastern Europe

Marketwired August 26, 2014

DIAGNOS Announces First Screening Unit In Argentina

Marketwired August 21, 2014

DIAGNOS Announces Changes to its Board of Directors

Marketwired July 24, 2014

DIAGNOS Announces Yet Another Expansion of Successful Program in the UAE

Marketwired July 22, 2014

DIAGNOS Announces Signing of Contract with Ministry of Health Owned Medical Center in the United Arab Emirates

Marketwired July 16, 2014

DIAGNOS Completes Merger with Warnex Inc. and Announces the Issuance of Stock Warrants

Marketwired July 8, 2014

DIAGNOS Announces Final Closing of Private Placement

Marketwired May 6, 2014

DIAGNOS Announces Final Closing of Private Placement

Marketwired May 6, 2014

DIAGNOS to Merge with Warnex

Marketwired May 5, 2014

DIAGNOS Announces Closing of First Tranche of Private Placement

Marketwired April 1, 2014

DIAGNOS Announces Closing of First Tranche of Private Placement

Marketwired April 1, 2014

DIAGNOS Announces an Additional Expansion of Successful Program in the UAE

Marketwired March 11, 2014